Compositions of chemically modified insulin

   
   

The present invention provides active, hydrophilic polymer-modified derivatives of insulin. The insulin derivatives of the invention are, in one aspect, suitable for delivery to the lung and exhibit pharmakokinetic and/or pharmacodynamic properties that are significantly improved over native insulin.

 
Web www.patentalert.com

< Bulk drying and the effects of inducing bubble nucleation

< Device and method for lysing cells, spores, or microorganisms

> Toner, image forming method, and image forming apparatus

> Water-dispersible, cationic polymers, a method of making same and items using same

~ 00186